Medicine and Dentistry
Transitional Cell Carcinoma
100%
Magnetic Resonance Imaging
71%
Neoplasm
70%
Computer Assisted Tomography
66%
Clear Cell Renal Cell Carcinoma
64%
Nephroureterectomy
51%
Angiomyolipoma
41%
Prostate Cancer
35%
Kidney Tumour
31%
Computed Tomography Urography
29%
Diffusion MRI
26%
Diagnosis
25%
Radiological Finding
23%
Urine Cytology
20%
Differential Diagnosis
17%
Contrast Medium
17%
Pelvis
16%
Partial Nephrectomy
15%
Diagnostic Performance
15%
Cancer Staging
14%
Body Mass Index
13%
Ureter
13%
Recurrent Disease
12%
Proton Nuclear Magnetic Resonance
11%
Neoadjuvant Chemotherapy
11%
Hydronephrosis
11%
Amyloidosis
11%
Mycobacterium Bovis BCG
11%
Contrast-Enhanced Ultrasound
11%
Bladder Disease
11%
Cystic Disease of the Kidney
11%
Pneumoperitoneum
11%
Primary Tumor
11%
Relaxometry
11%
Fibrinogen Plus Thrombin
11%
Pseudoaneurysm
11%
Glomerular Filtration Rate
11%
Cohort Analysis
11%
Epithelioma
11%
Operation Duration
11%
Clinical Trial
11%
Renal Cyst
11%
Stromal Tumor
11%
Multiparametric Magnetic Resonance Imaging
11%
Abdominal Radiology
11%
Immunoglobulin G4 Related Disease
11%
Biopsy Technique
11%
IgG4-Related Disease
11%
Intravenous Urography
10%
Renal Compensation
9%
Keyphrases
Nephroureterectomy
23%
Upper Tract Urothelial Carcinoma
23%
Computed Tomography Urography
17%
T2-weighted Imaging (T2WI)
13%
Urologists
11%
Preoperative Hydronephrosis
11%
Neoadjuvant Chemotherapy
11%
Low-flow Vascular Malformation
11%
Living Kidney Donor
11%
Radiologists
11%
TachoSil
11%
Vesical
11%
Fast Spin Echo
11%
Bladder
11%
Therapeutic Benefits
11%
T2 Contrast
11%
Bladder Pain Syndrome
11%
Angiomyolipoma with Epithelial Cysts
11%
Muscle-invasive Bladder Cancer
11%
Noncontrast-enhanced
11%
Weighted Shift
11%
Diagnostic Cystoscopy
11%
Tumor Contact Length
11%
Iterative Model
11%
Kidney Index
11%
Fat-poor
11%
Model-based Iterative Reconstruction
11%
Three-dimensional (3D)
11%
Pseudoenhancement
11%
Clinical Utility
11%
Multicenter Cohort Study
11%
Primary Cutaneous Amyloidosis
11%
Node-positive
11%
Data Systems
11%
Multiparametric MRI (mpMRI)
11%
Intravesical BCG Therapy
11%
Kidney Donation
11%
BCG Therapy
11%
Reporting System
11%
Kidney Volume
11%
Pre-donation
11%
Severe Hydronephrosis
11%
Abdominal Radiology
11%
Plasmacytoid Urothelial Carcinoma
11%
Omphalomesenteric Duct
11%
Umbilical Diseases
11%
Embryonic Remnants
11%
Radiograph
11%
IgG4-related Disease (IgG4-RD)
11%
Urethral Lesions
11%
